TP53 and acute myeloid leukemia: Briefly, our study showed association between TP53 rs1042522 and MDM4 rs4245739 variants and AML susceptibility, between TP53 rs1042522 and PLT count, NPM1 mutations (type A-D insertion), ELN, and cytogenetic risk.